Off an SEC filing from dec 2009Due to the complexity of RECAF technology, we believe that our proprietary know-how for developing the technology and working with the RECAF family of molecules is critical and extends beyond patented information. Accordingly, we include know-how in our licensing packages in order to obtain royalties in countries where we do not have patent protection.
KEY POINT: DUE TO THE COMPLEXITY OF RECAF Like I said earlier, if it were easy don't you think that someone would have cracked this wide open by now? It will happen.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.